ESC 365 - REDUCE LAP-HF I - Transcatheter InterAtrial Shunt Device for Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF I): 1-year Results from the Phase 2

ESC Premium Access

REDUCE LAP-HF I - Transcatheter InterAtrial Shunt Device for Heart Failure with Preserved Ejection Fraction (REDUCE LAP-HF I): 1-year Results from the Phase 2

Session: Late Breaking Science in Heart Failure

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor T. Feldman (Evanston, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Ted Feldman

Evanston Hospital Northshore, Evanston (United States of America)

7 presentations

0 follower

10 more presentations in this session

Panel discussants.

Panel discussion.

PROMIS-HFpEF - Microvascular dysfunction in heart failure with preserved ejection fraction (HFpEF): Evidence from the prospective multicenter PRevalence Of Microvascular dySfunction in HFpEF

Speaker: Professor C. Lam (Singapore, SG)

Panel discussion.

Safety and efficacy of neladenoson bialanate in patients with chronic heart failure and reduced ejection fraction.

Speaker: Professor A. Voors (Groningen, NL)

Access the full session

Late Breaking Science in Heart Failure

Speakers: Doctor T. Feldman, Professor C. Lam, Professor A. Voors

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources